AU7260098A - Diagnosis and treatment of phosphatase 0r kinase-related disorders - Google Patents

Diagnosis and treatment of phosphatase 0r kinase-related disorders

Info

Publication number: AU7260098A
Authority: AU; Australia
Prior art keywords: phosphatase; kinase; diagnosis; treatment; related disorders
Prior art date: 1997-04-28
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Abandoned

Application number

AU72600/98A

Inventor

Harald App

Douglas Clary

Sara A. Courtneidge

Terance H. Hui

Bahija Jallal

Dave Markby

Susan Onrust

Elior Peles

Greg D. Plowman

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Sugen LLC

Original Assignee

Sugen LLC

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-04-28

Filing date

1998-04-27

Publication date

1998-11-24

1998-04-27 Application filed by Sugen LLC filed Critical Sugen LLC

1998-11-24 Publication of AU7260098A publication Critical patent/AU7260098A/en

Status Abandoned legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
- C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Zoology (AREA)
Genetics & Genomics (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Wood Science & Technology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biochemistry (AREA)
General Health & Medical Sciences (AREA)
Biomedical Technology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
General Engineering & Computer Science (AREA)
Cell Biology (AREA)
Immunology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Biophysics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Enzymes And Modification Thereof (AREA)

AU72600/98A 1997-04-28 1998-04-27 Diagnosis and treatment of phosphatase 0r kinase-related disorders Abandoned AU7260098A (en)

Applications Claiming Priority (13)

Application Number	Priority Date	Filing Date	Title
US4442897P	1997-04-28	1997-04-28
US60044428		1997-04-28
US4722297P	1997-05-20	1997-05-20
US60047222		1997-05-20
US4975697P	1997-06-11	1997-06-11
US4947797P	1997-06-11	1997-06-11
US60049756		1997-06-11
US60049477		1997-06-11
US4991497P	1997-06-18	1997-06-18
US60049914		1997-06-18
US6359597P	1997-10-23	1997-10-23
US60063595		1997-10-23
PCT/US1998/008439 WO1998049317A2 (en)	1997-04-28	1998-04-27	Diagnosis and treatment of phosphatase- 0r kinase-related disorders

Publications (1)

Publication Number	Publication Date
AU7260098A true AU7260098A (en)	1998-11-24

Family

ID=27556472

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AU72600/98A Abandoned AU7260098A (en)	1997-04-28	1998-04-27	Diagnosis and treatment of phosphatase 0r kinase-related disorders

Country Status (5)

Country	Link
EP (1)	EP0979288A2 (en)
JP (1)	JP2002513289A (en)
AU (1)	AU7260098A (en)
CA (1)	CA2288221A1 (en)
WO (1)	WO1998049317A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2220853A1 (en) *	1998-01-16	1999-07-16	Hsc Research And Development Limited Partnership	Human lymphoid protein tyrosine phosphatases
WO2000063392A1 (en) *	1999-04-16	2000-10-26	Kyowa Hakko Kogyo Co., Ltd.	Novel tyrosine phosphatase
EP1046715A1 (en) *	1999-04-23	2000-10-25	Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.	Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2
CA2394753A1 (en) *	2000-01-18	2001-07-26	Human Genome Sciences, Inc.	Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
WO2002042435A2 (en) *	2000-11-27	2002-05-30	Bayer Aktiengesellschaft	Regulation of human tyrosine phosphatase
DK1454992T3 (en) *	2003-03-07	2006-10-02	Ist Naz Stud Cura Dei Tumori	Anaplastic lymphoma kinase assay, reagents and compositions thereof
CA2558478A1 (en)	2004-03-02	2005-09-15	Acceleron Pharma Inc.	Alk7 and myostatin inhibitors and uses thereof
WO2007037532A1 (en) *	2005-09-30	2007-04-05	Link Genomics, Inc.	Therapeutic or diagnostic application of srms gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5294538A (en) *	1991-11-18	1994-03-15	Cold Spring Harbor Labs.	Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase
NZ273219A (en) *	1993-09-01	1998-06-26	Ludwig Inst Cancer Res	Nucleotide sequences for protein tyrosine phosphatases
US5830648A (en) *	1995-05-05	1998-11-03	Sugen, Inc.	Assay and method for transcript imaging

1998
- 1998-04-27 JP JP54724498A patent/JP2002513289A/en not_active Ceased
- 1998-04-27 AU AU72600/98A patent/AU7260098A/en not_active Abandoned
- 1998-04-27 WO PCT/US1998/008439 patent/WO1998049317A2/en not_active Application Discontinuation
- 1998-04-27 CA CA002288221A patent/CA2288221A1/en not_active Abandoned
- 1998-04-27 EP EP98919919A patent/EP0979288A2/en not_active Withdrawn

Also Published As

Publication number	Publication date
WO1998049317A2 (en)	1998-11-05
WO1998049317A3 (en)	1999-02-25
EP0979288A2 (en)	2000-02-16
JP2002513289A (en)	2002-05-08
CA2288221A1 (en)	1998-11-05

Similar Documents

Publication	Publication Date	Title
AU6974996A (en)	1997-05-15	Compositions for the treatment of dermatological disorders and methods for their use
AU6744798A (en)	1998-10-22	Health condition monitor and method of use
IL133800A0 (en)	2001-04-30	Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AU2124397A (en)	1997-09-02	Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2209697A (en)	1997-10-01	Fluorocarbons for diagnosis and treatment of articular disorders
AU4054297A (en)	1998-03-19	Manipulations of nitrosative and oxidatives stress in the treatment of disease
AU1575697A (en)	1997-08-01	Compositions and methods for the treatment and diagnosis of cancer
AU2749395A (en)	1996-01-19	Medical use of bromelain
AU9395998A (en)	1999-04-05	Compositions and methods for the treatment of immune related diseases
AU1556497A (en)	1997-08-22	Agents for the treatment and prevention of aids
AU1578295A (en)	1995-08-29	Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
AU3760400A (en)	2000-10-09	Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU2513997A (en)	1997-10-29	Diagnosis and monitoring of neurological disease
AU8479498A (en)	1999-02-08	Dual specificity phosphatase and methods of use
AU7260098A (en)	1998-11-24	Diagnosis and treatment of phosphatase 0r kinase-related disorders
HUP0000785A3 (en)	2000-12-28	Ointment for the treatment of burns and other skin diseases
AUPN104895A0 (en)	1995-03-09	Methods of and preparations for the treatment of ailments and disorders
AU6786598A (en)	1998-10-20	Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU2913397A (en)	1998-12-30	Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
AU4841296A (en)	1996-09-04	Diagnosis of and compositions and methods for the treatment of disease
AU6653698A (en)	1998-08-26	Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU1408999A (en)	1999-06-07	Detection and treatment of retinal degenerative disease
AU6786798A (en)	1998-10-20	Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU8580598A (en)	1999-02-16	Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU4575897A (en)	1998-05-11	Pharmaceutical and diagnostic use of serum amyloid p component

Legal Events

Date	Code	Title	Description
2000-02-03	MK6	Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase